nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

18.04.2023 | Review

Molecular insights into placental iron transfer mechanisms and maternofetal regulation

verfasst von: Sreenithi Santhakumar, Eunice S. Edison

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Adequate iron transportation from the mother across the placenta is crucial for fetal growth and establishing sufficient iron stores in neonates at birth. The past decade has marked significant discoveries in iron metabolism with the identification of new players and mechanisms. Immunohistochemical studies rendered valuable data on the localization of substantial iron transporters on placental syncytiotrophoblasts. However, the function and regulation of maternal-placentofetal iron transporters and iron handling is still elusive and requires more attention.

Methods

A thorough literature review was conducted to gather information about placental iron transfer, the role of regulators and maintenance of iron homeostasis.

Results

The role of classical and new players in maternal-fetal iron transport and the regulation in the placenta has been addressed in this review. Animal and human studies have been discussed. The role of placental iron regulation in thalassemia and hemochromatosis pregnancies has been reviewed.

Conclusions

The current advances that highlight the mechanisms of placental iron regulation and transport in response to maternal and fetal signals have been presented.

“WHO guidance helps detect iron deficiency and protect brain development.” https://www.who.int/news/item/20-04-2020-who-guidance-helps-detect-iron-deficiency-and-protect-brain-development (accessed Dec. 23, 2022).

Georgieff MK (2020) Iron deficiency in pregnancy. Am J Obstet Gynecol 223(4):516–524. https://doi.org/10.1016/j.ajog.2020.03.006CrossRefPubMedPubMedCentral

Yang Z et al (2009) Prevalence and predictors of iron deficiency in fully breastfed infants at 6 mo of age: comparison of data from 6 studies. Am J Clin Nutr 89(5):1433–1440. https://doi.org/10.3945/ajcn.2008.26964CrossRefPubMed

H. Kay, D. M. Nelson, and Y. Wang, The Placenta: From Development to Disease. Wiley, 2011.

Roberts H, Bourque SL, Renaud SJ (2020) Maternal iron homeostasis: effect on placental development and function. Reproduction 160(4):R65–R78. https://doi.org/10.1530/REP-20-0271CrossRefPubMed

Soares MJ, Varberg KM, Iqbal K (2018) Hemochorial placentation: development, function, and adaptations. Biol Reprod 99(1):196–211. https://doi.org/10.1093/biolre/ioy049CrossRefPubMedPubMedCentral

Polin RA, Fox WW, Abman SH (2011) Fetal and neonatal physiology e-book, 4th edn. Elsevier Health Sciences, Philadelphia, PA

McArdle HJ, Lang C, Hayes H, Gambling L (2011) Role of the placenta in regulation of fetal iron status. Nutr Rev 69(s1):S17–S22. https://doi.org/10.1111/j.1753-4887.2011.00428.xCrossRefPubMed

“Estrogen-enhanced apical and basolateral secretion of apolipoprotein B-100 by polarized trophoblast-derived BeWo cells - ScienceDirect.” https://www.sciencedirect.com/science/article/abs/pii/S0300908417301189?via%3Dihub (accessed Jun. 15, 2022).

10.

Deyssenroth MA, Peng S, Hao K, Lambertini L, Marsit CJ, Chen J (2017) Whole-transcriptome analysis delineates the human placenta gene network and its associations with fetal growth. BMC Genom 18(1):520. https://doi.org/10.1186/s12864-017-3878-0CrossRef

11.

Perez-Garcia V et al (2018) Placentation defects are highly prevalent in embryonic lethal mouse mutants. Nature 555(7697):463–468. https://doi.org/10.1038/nature26002CrossRefPubMedPubMedCentral

12.

Edison ES, Bajel A, Chandy M (2008) Iron homeostasis: new players, newer insights. Eur J Haematol 81(6):411–424. https://doi.org/10.1111/j.1600-0609.2008.01143.xCrossRefPubMed

13.

Cao C, Fleming MD (2016) The placenta: the forgotten essential organ of iron transport. Nutr Rev 74(7):421–431. https://doi.org/10.1093/nutrit/nuw009CrossRefPubMedPubMedCentral

14.

Gunes T et al (2016) Maternal and cord blood hepcidin levels based on gestational weeks in term and preterm infants. Pediatr Hematol Oncol J 1(2):23–27. https://doi.org/10.1016/j.phoj.2016.07.007CrossRef

15.

Bothwell TH (2000) Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 72(1 Suppl):257s–264s. https://doi.org/10.1093/ajcn/72.1.257SCrossRefPubMed

16.

Gassmann B (1991) Requirements of Vitamin A, iron, folate and Vitamin B12. report of joint FAO/WHO expert consultation. 107 Seiten, 5 Abb., 24 Tab. food and agriculture organization of the United Nations; Rome 1988. Food Nahr 35(1):20–20. https://doi.org/10.1002/food.19910350104CrossRef

17.

Sharma MSJB (2010) “Anemia in Pregnancy,”. JIMSA, 23(4)

18.

WHO, 2012 “WHO Guidelines Approved by the Guidelines Review Committee,” in Guideline: Daily Iron and Folic Acid Supplementation in Pregnant Women, Geneva: World Health Organization World Health Organization.

19.

Rioux FM, LeBlanc CP (2007) Iron supplementation during pregnancy: what are the risks and benefits of current practices? Appl Physiol Nutr Metab Physiol Appl Nutr Metab 32(2):282–288. https://doi.org/10.1139/H07-012CrossRef

20.

Ramakrishnan U et al (2004) Multiple micronutrient supplements during pregnancy do not reduce anemia or improve iron status compared to iron-only supplements in Semirural Mexico. J Nutr 134(4):898–903. https://doi.org/10.1093/jn/134.4.898CrossRefPubMed

21.

Milman N (2012) Oral iron prophylaxis in pregnancy: not too little and not too much! J Pregnancy 2012:514345. https://doi.org/10.1155/2012/514345CrossRefPubMedPubMedCentral

22.

Mathan VI, Baker SJ, Sood SK, Ramachandran K, Ramalingaswami V (1979) WHO sponsored collaborative studies on nutritional anaemia in India. The effects of ascorbic acid and protein supplementation on the response of pregnant women to iron, pteroylglutamic acid and cyanocobalamin therapy. Br J Nutr 42(3):391–398CrossRefPubMed

23.

Rai R, Fawzi W, Barik A, Chowdhury A (2018) The burden of iron-deficiency anaemia among women in India: how have iron and folic acid interventions fared? WHO South-East Asia J Public Health 7(1):18–23. https://doi.org/10.4103/2224-3151.228423CrossRefPubMed

24.

Gautam CS, Saha L, Sekhri K, Saha PK (2008) Iron deficiency in pregnancy and the rationality of iron supplements prescribed during pregnancy. Medscape J Med 10(12):283PubMedPubMedCentral

25.

Lurie S, Mamet Y (2001) Red blood cell survival and inetics during pregnancy. Eur J Obstet Gynecol Reprod Biol 93:185–192. https://doi.org/10.1016/S0301-2115(00)00290-6CrossRef

26.

Vricella LK (2017) Emerging understanding and measurement of plasma volume expansion in pregnancy. Am J Clin Nutr 106(Suppl 6):1620S-1625S. https://doi.org/10.3945/ajcn.117.155903CrossRefPubMedPubMedCentral

27.

Fisher AL, Nemeth E (2017) Iron homeostasis during pregnancy. Am J Clin Nutr 106(Suppl 6):1567s–1574s. https://doi.org/10.3945/ajcn.117.155812CrossRefPubMedPubMedCentral

28.

Suominen P, Punnonen K, Rajamaki A, Irjala K (1998) Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood 92(8):2934–2939CrossRefPubMed

29.

WHO/UNICEF/UNU, 2001 “Iron Deficiency Anemia: Assessment,Prevention and Control. A Guide for Programme Managers.Geneva, World Health Organization,”

30.

Daru J, Colman K, Stanworth SJ, De La Salle B, Wood EM, Pasricha SR (2017) Serum ferritin as an indicator of iron status: what do we need to know? Am J Clin Nutr 106(Suppl 6):1634S-1639S. https://doi.org/10.3945/ajcn.117.155960CrossRefPubMedPubMedCentral

31.

Choi JW, Im MW, Pai SH (2000) Serum transferrin receptor concentrations during normal pregnancy. Clin Chem 46(5):725–727CrossRefPubMed

32.

Zaman B, Rasool S, Jasim S, Abdulah D (2019) Hepcidin as a diagnostic biomarker of iron deficiency anemia during pregnancy. J Matern Fetal Neonatal Med. https://doi.org/10.1080/14767058.2019.1635112CrossRefPubMed

33.

Torti SV, Torti FM (2013) Iron and cancer: more ore to be mined. Nat Rev Cancer 13(5):342–355. https://doi.org/10.1038/nrc3495CrossRefPubMedPubMedCentral

34.

Georgieff MK, Berry SA, Wobken JD, Leibold EA (1999) Increased placental iron regulatory protein-1 expression in diabetic pregnancies complicated by fetal iron deficiency. Placenta 20(1):87–93. https://doi.org/10.1053/plac.1998.0339CrossRefPubMed

35.

Bradley J et al (2004) Influence of gestational age and fetal iron status on IRP activity and iron transporter protein expression in third-trimester human placenta. Am J Physiol Regul Integr Comp Physiol 287(4):R894-901. https://doi.org/10.1152/ajpregu.00525.2003CrossRefPubMed

36.

Chong WS, Kwan PC, Chan LY, Chiu PY, Cheung TK, Lau TK (2005) Expression of divalent metal transporter 1 (DMT1) isoforms in first trimester human placenta and embryonic tissues. Hum Reprod 20(12):3532–3538. https://doi.org/10.1093/humrep/dei246CrossRefPubMed

37.

Sangkhae V et al (2019) Effects of maternal iron status on placental and fetal iron homeostasis. J Clin Invest. https://doi.org/10.1172/jci127341CrossRefPubMedCentral

38.

Silvestri L, Nai A, Dulja A, Pagani A (2019) Hepcidin and the BMP-SMAD pathway: an unexpected liaison. Vitam Horm 110:71–99. https://doi.org/10.1016/bs.vh.2019.01.004CrossRefPubMed

39.

Tandara L, Salamunic I (2012) Iron metabolism: current facts and future decisions. Biochem Med Zagreb 22(3):311–328. https://doi.org/10.11613/bm.2012.034CrossRefPubMedPubMedCentral

40.

Mégier C, Peoch K, Puy V, Cordier AG (2022) Iron metabolism in normal and pathological pregnancies and fetal consequences. Metabolites 12(2):129. https://doi.org/10.3390/metabo12020129CrossRefPubMedPubMedCentral

41.

Guo Y et al (2019) Iron homeostasis in pregnancy and spontaneous abortion. Am J Hematol 94(2):184–188. https://doi.org/10.1002/ajh.25341CrossRefPubMed

42.

Kulik-Rechberger B, Kosciesza A, Szponar E, Domosud J (2016) Hepcidin and iron status in pregnant women and full-term newborns in first days of life. Ginekol Pol 87(4):288–292. https://doi.org/10.17772/gp/62202CrossRefPubMed

43.

McDonald EA, Gundogan F, Olveda RM, Bartnikas TB, Kurtis JD, Friedman JF (2022) Iron transport across the human placenta is regulated by hepcidin. Pediatr Res 92(2):396–402. https://doi.org/10.1038/s41390-020-01201-yCrossRefPubMed

44.

Kammerer L, Mohammad G, Wolna M, Robbins P, Lakhal-Littleton S (2019) Fetal liver hepcidin supports acquisition of iron stores in utero. Biorxiv. https://doi.org/10.1101/799304CrossRef

45.

Gambling L et al (2009) Fetal iron status regulates maternal iron metabolism during pregnancy in the rat. Am J Physiol Regul Integr Comp Physiol 296(4):R1063–R1070. https://doi.org/10.1152/ajpregu.90793.2008CrossRefPubMed

46.

Nicolas G et al (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U A 99(7):4596–4601. https://doi.org/10.1073/pnas.072632499CrossRef

47.

Willemetz A et al (2014) Matriptase-2 is essential for hepcidin repression during fetal life and postnatal development in mice to maintain iron homeostasis. Blood 124(3):441–444. https://doi.org/10.1182/blood-2014-01-551150CrossRefPubMed

48.

Basu S, Kumar N, Srivastava R, Kumar A (2016) Maternal and cord blood hepcidin concentrations in severe iron deficiency Anemia. Pediatr Neonatol 57(5):413–419. https://doi.org/10.1016/j.pedneo.2015.09.012CrossRefPubMed

49.

Rehu M et al (2010) Maternal serum hepcidin is low at term and independent of cord blood iron status. Eur J Haematol 85(4):345–352. https://doi.org/10.1111/j.1600-0609.2010.01479.xCrossRefPubMed

50.

Koenig MD, Tussing-Humphreys L, Day J, Cadwell B, Nemeth E (2014) Hepcidin and iron homeostasis during pregnancy. Nutrients 6(8):3062–3083. https://doi.org/10.3390/nu6083062CrossRefPubMedPubMedCentral

51.

Young MF et al (2012) Maternal hepcidin is associated with placental transfer of iron derived from dietary heme and nonheme sources. J Nutr 142(1):33–39. https://doi.org/10.3945/jn.111.145961CrossRefPubMed

52.

Tanno T et al (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13(9):1096–1101. https://doi.org/10.1038/nm1629CrossRefPubMed

53.

Tanno T et al (2009) Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114(1):181–186. https://doi.org/10.1182/blood-2008-12-195503CrossRefPubMedPubMedCentral

54.

Arezes J et al (2018) Erythroferrone inhibits the induction of hepcidin by BMP6. Blood 132(14):1473–1477. https://doi.org/10.1182/blood-2018-06-857995CrossRefPubMedPubMedCentral

55.

Finkenstedt A et al (2012) Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy. Blood Cells Mol Dis 48(4):233–237. https://doi.org/10.1016/j.bcmd.2012.02.001CrossRefPubMed

56.

Coffey R, Ganz T (2018) Erythroferrone: an erythroid regulator of hepcidin and iron metabolism. HemaSphere 2(2):e35. https://doi.org/10.1097/HS9.0000000000000035CrossRefPubMedPubMedCentral

57.

Delaney KM, Guillet R, Pressman EK, Ganz T, Nemeth E, O’Brien KO (2021) Umbilical cord erythroferrone is inversely associated with hepcidin, but does not capture the most variability in iron status of neonates born to teens carrying singletons and women carrying multiples. J Nutr 151(9):2590–2600. https://doi.org/10.1093/jn/nxab156CrossRefPubMedPubMedCentral

58.

Delaney KM, Guillet R, Pressman EK, Ganz T, Nemeth E, O’Brien KO (2021) Serum erythroferrone during pregnancy is related to erythropoietin but does not predict the Risk of Anemia. J Nutr 151(7):1824–1833. https://doi.org/10.1093/jn/nxab093CrossRefPubMedPubMedCentral

59.

Wei S et al (2021) Disordered serum erythroferrone and hepcidin levels as indicators of the spontaneous abortion occurrence during early pregnancy in humans. Br J Haematol 192(3):643–651. https://doi.org/10.1111/bjh.17049CrossRefPubMed

60.

Dacks PA (2012) Estrogens iron out the details: a novel direct pathway for estrogen control of iron homeostasis. Endocrinology 153(7):2942–2944. https://doi.org/10.1210/en.2012-1480CrossRefPubMed

61.

Morel Y, Roucher F, Plotton I, Goursaud C, Tardy V, Mallet D (2016) Evolution of steroids during pregnancy: Maternal, placental and fetal synthesis. Ann Endocrinol Paris 77(2):82–89. https://doi.org/10.1016/j.ando.2016.04.023CrossRefPubMed

62.

Mukundan H, Resta TC, Kanagy NL (2002) 17Beta-estradiol decreases hypoxic induction of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol 283(2):R496-504. https://doi.org/10.1152/ajpregu.00573.2001CrossRefPubMed

63.

Horiguchi H, Oguma E, Kayama F (2005) The effects of iron deficiency on estradiol-induced suppression of erythropoietin induction in rats: implications of pregnancy-related anemia. Blood 106(1):67–74. https://doi.org/10.1182/blood-2004-06-2350CrossRefPubMed

64.

Yang Q, Jian J, Katz S, Abramson SB, Huang X (2012) 17beta-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 153(7):3170–3178. https://doi.org/10.1210/en.2011-2045CrossRefPubMedPubMedCentral

65.

Hou Y et al (2012) Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene 511(2):398–403. https://doi.org/10.1016/j.gene.2012.09.060CrossRefPubMed

66.

Shero N, Fiset S, Plamondon H, Thabet M, Rioux FM (2018) Increase serum cortisol in young guinea pig offspring in response to maternal iron deficiency. Nutr Res 54:69–79. https://doi.org/10.1016/j.nutres.2018.03.017CrossRefPubMed

67.

Hurrell R, Egli I (2010) Iron bioavailability and dietary reference values. Am J Clin Nutr 91(5):1461s–1467s. https://doi.org/10.3945/ajcn.2010.28674FCrossRefPubMed

68.

Cao C, O’Brien KO (2013) Pregnancy and iron homeostasis: an update. Nutr Rev 71(1):35–51. https://doi.org/10.1111/j.1753-4887.2012.00550.xCrossRefPubMed

69.

Harris ED (1992) New insights into placental iron transport. Nutr Rev 50(11):329–331. https://doi.org/10.1111/j.1753-4887.1992.tb07719.xCrossRefPubMed

70.

O’Brien KO (2022) Maternal, fetal and placental regulation of placental iron trafficking. Placenta 125:47–53. https://doi.org/10.1016/j.placenta.2021.12.018CrossRefPubMed

71.

King BF (1976) Localization of transferrin on the surface of the human placenta by electron microscopic immunocytochemistry. Anat Rec 186(2):151–159. https://doi.org/10.1002/ar.1091860203CrossRefPubMed

72.

Parmley RT, Barton JC, Conrad ME (1985) Ultrastructural localization of transferrin, transferrin receptor, and iron-binding sites on human placental and duodenal microvilli. Br J Haematol 60(1):81–89. https://doi.org/10.1111/j.1365-2141.1985.tb07388.xCrossRefPubMed

73.

Cao C, Fleming MD (2021) Localization and kinetics of the transferrin-dependent iron transport machinery in the mouse placenta. Curr Dev Nutr 5(4):25. https://doi.org/10.1093/cdn/nzab025CrossRef

74.

Afar et al, 2006 “Antibodies immunospecific for STEAP1,” U. S. Pat.,

75.

Ohgami RS, Campagna DR, McDonald A, Fleming MD (2006) The Steap proteins are metalloreductases. Blood 108(4):1388–1394. https://doi.org/10.1182/blood-2006-02-003681CrossRefPubMedPubMedCentral

76.

Li YQ et al (2012) Divalent metal transporter 1 expression and regulation in human placenta. Biol Trace Elem Res 146(1):6–12. https://doi.org/10.1007/s12011-011-9214-7CrossRefPubMed

77.

Bastin J, Drakesmith H, Rees M, Sargent I, Townsend A (2006) Localisation of proteins of iron metabolism in the human placenta and liver. Br J Haematol 134(5):532–543. https://doi.org/10.1111/j.1365-2141.2006.06216.xCrossRefPubMed

78.

Li Y-Q, Bai B, Cao X-X, Yan H, Zhuang G-H (2012) Ferroportin 1 and hephaestin expression in BeWo cell line with different iron treatment. Cell Biochem Funct 30(3):249–255. https://doi.org/10.1002/cbf.1843CrossRefPubMed

79.

Helman SL, Frazer DM, Anderson GJ, Wilkins SJ (2022) Disruption of Hephaestin in the Placenta and Fetus Leads to Fetal Anemia. Blood 140(Supplement 1):2196. https://doi.org/10.1182/blood-2022-167810CrossRef

80.

Fryer AA, Jones P, Strange R, Hume R, Bell JE (1993) Plasma protein levels in normal human fetuses: 13 to 41 weeks’ gestation. Br J Obstet Gynaecol 100(9):850–855. https://doi.org/10.1111/j.1471-0528.1993.tb14313.xCrossRefPubMed

81.

Helman SL et al (2021) The placental ferroxidase Zyklopen is not essential for iron transport to the fetus in mice. J Nutr 151(9):2541–2550. https://doi.org/10.1093/jn/nxab174CrossRefPubMed

82.

“Endocytosis in the placenta: An undervalued mediator of placental transfer - PubMed.” https://pubmed.ncbi.nlm.nih.gov/33994009/ (accessed Dec. 09, 2022).

83.

Levy JE, Jin O, Fujiwara Y, Kuo F, Andrews NC (1999) Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 21(4):396–399. https://doi.org/10.1038/7727CrossRefPubMed

84.

Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, Moestrup SK (2005) Identification of the receptor scavenging hemopexin-heme complexes. Blood 106(7):2572–2579. https://doi.org/10.1182/blood-2005-03-1185CrossRefPubMed

85.

Smith A, Ledford BE (1988) Expression of the haemopexin-transport system in cultured mouse hepatoma cells. Links between haemopexin and iron metabolism. Biochem J 256(3):941–950. https://doi.org/10.1042/bj2560941CrossRefPubMedPubMedCentral

86.

Quigley JG et al (2004) Identification of a human heme exporter that is essential for erythropoiesis. Cell 118(6):757–766. https://doi.org/10.1016/j.cell.2004.08.014CrossRefPubMed

87.

Cao C, Pressman EK, Cooper EM, Guillet R, Westerman M, O’Brien KO (2014) Placental heme receptor LRP1 correlates with the heme exporter FLVCR1 and neonatal iron status. Reproduction 148(3):295–302. https://doi.org/10.1530/rep-14-0053CrossRefPubMedPubMedCentral

88.

Inoue R, Irie Y, Akagi R (2021) Role of heme oxygenase-1 in human placenta on iron supply to Fetus. Placenta 103:53–58. https://doi.org/10.1016/j.placenta.2020.09.065CrossRefPubMed

89.

Best CM et al (2016) Maternal iron status during pregnancy compared with neonatal iron status better predicts placental iron transporter expression in humans. Faseb J 30(10):3541–3550. https://doi.org/10.1096/fj.201600069RCrossRefPubMedPubMedCentral

90.

Garbowski MW, Ma Y, Fucharoen S, Srichairatanakool S, Hider R, Porter JB (2016) Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay. Transl Res 177:19-30.e5. https://doi.org/10.1016/j.trsl.2016.05.005CrossRefPubMedPubMedCentral

91.

Koba M, Socha E, Słomka A, Żekanowska E, Socha M, Grabiec M (2017) The ability to determine the non-transferrin-bound iron and total iron in the human placenta using high-performance liquid chromatography method. Med Res J 2(4):181–185. https://doi.org/10.5603/MRJ.2017.0026CrossRef

92.

Kalhan TG, Bateman DA, Bowker RM, Hod EA, Kashyap S (2017) Effect of red blood cell storage time on markers of hemolysis and inflammation in transfused very low birth weight infants. Pediatr Res 82(6):964–969. https://doi.org/10.1038/pr.2017.177CrossRefPubMedPubMedCentral

93.

Evans P, Cindrova-Davies T, Muttukrishna S, Burton GJ, Porter J, Jauniaux E (2011) Hepcidin and iron species distribution inside the first-trimester human gestational sac. Mol Hum Reprod 17(4):227–232. https://doi.org/10.1093/molehr/gaq101CrossRefPubMed

94.

Sangkhae V, Nemeth E (2019) Placental iron transport: The mechanism and regulatory circuits. Free Radic Biol Med 133:254–261. https://doi.org/10.1016/j.freeradbiomed.2018.07.001CrossRefPubMed

95.

Cc T 3rd, Dr C, Vm S, Nc A, Md F (2000) The molecular defect in hypotransferrinemic mice. Blood 96(3):1113–1118CrossRef

96.

Girijashanker K et al (2008) Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol Pharmacol 73(5):1413–1423. https://doi.org/10.1124/mol.107.043588CrossRefPubMed

97.

Donovan A et al (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1(3):191–200. https://doi.org/10.1016/j.cmet.2005.01.003CrossRefPubMed

98.

Drakesmith H, Nemeth E, Ganz T (2015) Ironing out Ferroportin. Cell Metab 22(5):777–787. https://doi.org/10.1016/j.cmet.2015.09.006CrossRefPubMedPubMedCentral

99.

Cao C, Fleming MD (2022) Loss of the placental iron exporter ferroportin 1 causes embryonic demise in late-gestation mouse pregnancy. Development 149(23):201160. https://doi.org/10.1242/dev.201160CrossRef

100.

Ganz T (2011) Hepcidin and iron regulation, 10 years later. Blood 117(17):4425–4433. https://doi.org/10.1182/blood-2011-01-258467CrossRefPubMedPubMedCentral

101.

Gunshin H, Fujiwara Y, Custodio AO, DiRenzo C, Robine S, Andrews NC (2005) Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest 115(5):1258–1266. https://doi.org/10.1172/JCI24356CrossRefPubMedPubMedCentral

102.

Panaitescu AM, Peltecu G (2016) Gestational diabetes. obstetrical perspective. Acta Endocrinol Buchar 12(3):331–334. https://doi.org/10.4183/aeb.2016.331CrossRefPubMedPubMedCentral

103.

Chen X, Scholl TO, Stein TP (2006) Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women: The Camden study. Diabetes Care 29(5):1077–1082. https://doi.org/10.2337/diacare.2951077CrossRefPubMed

104.

Bowers KA, Olsen SF, Bao W, Halldorsson TI, Strom M, Zhang C (2016) Plasma concentrations of ferritin in early pregnancy are associated with risk of gestational diabetes Mellitus in women in the Danish National Birth Cohort. J Nutr 146(9):1756–1761. https://doi.org/10.3945/jn.115.227793CrossRefPubMedPubMedCentral

105.

Rawal S et al (2017) A longitudinal study of iron status during pregnancy and the risk of gestational diabetes: findings from a prospective, multiracial cohort. Diabetologia 60(2):249–257. https://doi.org/10.1007/s00125-016-4149-3CrossRefPubMed

106.

Yang A et al (2016) Expression of hepcidin and ferroportin in the placenta, and ferritin and transferrin receptor 1 levels in maternal and umbilical cord blood in pregnant women with and without gestational diabetes. Int J Env. Res Public Health 13(8):766. https://doi.org/10.3390/ijerph13080766CrossRef

107.

Sokoloff A, Brook S, Cooper M (2009) Iron Studies in hemochromatosis during pregnancy. Blood 114(22):5099–5099CrossRef

108.

Baynes RD, Meyer TE, Bothwell TH, Lamparelli RD (1991) Maternal and fetal iron measurements in a hemochromatotic pregnancy. Am J Hematol 36(1):48–49. https://doi.org/10.1002/ajh.2830360110CrossRefPubMed

109.

Feldman AG, Whitington PF (2013) Neonatal hemochromatosis. J Clin Exp Hepatol 3(4):313–320. https://doi.org/10.1016/j.jceh.2013.10.004CrossRefPubMedPubMedCentral

110.

Shimono A et al (2016) An immunohistochemical study of placental syncytiotrophoblasts in neonatal hemochromatosis. Placenta 48:49–55. https://doi.org/10.1016/j.placenta.2016.10.005CrossRefPubMed

111.

Petrakos G, Andriopoulos P, Tsironi M (2016) Pregnancy in women with thalassemia: challenges and solutions. Int J Womens Health 8:441–451. https://doi.org/10.2147/IJWH.S89308CrossRefPubMedPubMedCentral

112.

R. Origa, “Beta-Thalassemia,” in GeneReviews®, M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, K. Stephens, and A. Amemiya, Eds. Seattle (WA): University of Washington, Seattle, 1993. Accessed: Nov. 11, 2020. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK1426/

113.

Artico M et al (2004) Direct demonstration of iron in a term placenta in two cases of beta-thalassemia. Am J Hematol 75(4):241–242. https://doi.org/10.1002/ajh.20005CrossRefPubMed

114.

Pearson HA (2007) Iron studies in infants born to an iron overloaded mother with beta-thalassemia major: possible effects of maternal desferrioxamine therapy. J Pediatr Hematol Oncol 29(3):160–162. https://doi.org/10.1097/MPH.0b013e31803b957dCrossRefPubMed

115.

Lee BS, Sathar J, Sivapatham L, Lee LI (2018) Pregnancy outcomes in women with non-transfusion dependent thalassaemia (NTDT): A haematology centre experience. Malays J Pathol 40(2):149–152PubMed

116.

Vlachodimitropoulou E, Thomas A, Shah F, Kyei-Mensah A (2018) Pregnancy and iron status in β-thalassaemia major and intermedia: six years’ experience in a North London Hospital. J Obstet Gynaecol 38(4):567–570. https://doi.org/10.1080/01443615.2017.1342616CrossRefPubMed

Titel: Molecular insights into placental iron transfer mechanisms and maternofetal regulation
verfasst von: Sreenithi Santhakumar
Eunice S. Edison
Publikationsdatum: 18.04.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 1/2024
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-023-07032-6

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Molecular insights into placental iron transfer mechanisms and maternofetal regulation

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Update Gynäkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Diagnostic yield of copy number variation sequencing in fetuses with increased nuchal translucency: a retrospective study

Latissimus dorsi flap for breast reconstruction: a large single-institution evaluation of surgical outcome and complications

Fetal aortic isthmus Doppler assessment to predict the adverse perinatal outcomes associated with fetal growth restriction: systematic review and meta-analysis

Editorial Expression of Concern: Reproductive performance in the next pregnancy for nulliparous women with history of first trimester spontaneous abortion

Status quo and future directions of digitalization in gynecology and obstetrics in Germany: a survey of the commission Digital Medicine of the German Society for Gynecology and Obstetrics

Effects of timing of umbilical cord clamping for mother and newborn: a narrative review

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Update Gynäkologie